Newsletter | May 14, 2022

05.14.22 -- Gene Cargos: Building A Bigger Ship
 
Featured Editorial
Emerging Trends In Cell And Gene Therapies For Immuno-Oncology
By Chris Dokomajilar, Christopher Leidli, and Jim Grady
Gene Cargos: Building A Bigger Ship
By Matthew Pillar, Editor, BioProcess Online
Regulatory Requirements For CAR-T Starting Materials
By W. Schaut, B. Jones, and R. Bowden, Ph.D., Janssen Pharmaceuticals, Inc.
The CAR T Speed Show
By Matthew Pillar, Editor, BioProcess Online
5 Ways For Emerging Biotechs To Launch Smarter
By Eduardo Schur, EY
How To Build A Genomic Medicine Biotech
By Matthew Pillar, editor, Bioprocess Online
Industry Insights
Conservative vs. Progressive Approaches To Quality By Design
By Jason Dickens and Mike Ponstingl
Strategies For API Solubility And Bioavailability Enhancement
By Sanjay Konagurthu, Ph.D., and Tom Reynolds
Seed Train Intensification Using High Cell Density Cryopreservation
By Mona Bausch, Melanie Brandl, Ph.D., and Habib Horry, Ph.D.
Evaluation: Dynamic Binding Capacity And Residence Time
By C. Zheng, F. Han, et al.
Risk Management And The Combination Product Testing Strategy
By D. Bantz
Three Reasons Integrated CDMO Models Are Best
Pfizer CentreOne
Changing The Status Quo Of Vaccine Production
Precision NanoSystems
Consistency And Compliance: Cell Therapy Automation Software
Cytiva
Cell Culture Media Analysis For Gene Therapy
908 Devices
Selecting The Best Transfection Method
Mirus Bio LLC
Manufacturing Dry Powder Inhaled Formulations By Spray Drying
Lonza
Inside Bioprocessing Podcast: Microbial Bioproduction
Thermo Fisher Scientific
Getting Ready For SUT X-Ray Irradiation
Pall Corporation
Embrace Molecule Complexity With Optimized Expression Technologies
Lonza
Accelerated Tech Transfer For A COVID-19 Program
Samsung Biologics
Which Testing Does An Effective Certificate Of Analysis Include?
By Ken Chomistek
Expanding The Boundaries Of Sub-Cutaneous Injections
By Ahmed Besheer
Optimization Of A Glycosylation Analytical Method
By Eliza Yeung, Ph.D., and Philip Ramsey, Ph.D.
Controlling Risk: Poor Analyte Recovery And Lack Of Assay Robustness
By Nilini Ranbaduge, Robert E. Birdsall, et al.
Successful Control Strategies: Part 1
By Daniel L. Kirschner, Ph.D., and Tom Lovelace
Extreme Biobanking
By Sheri Gimigliano and Debra Barnes, Ph.D.
How To Secure A Sustainable Supply Of Raw Materials
Pfizer CentreOne
How Microbial Fermentation And Protein Biomanufacturing Works
Luina Bio
Adherent Versus Suspension Processes For Viral Vector Manufacturing
AGC Biologics
Outsourcing Process Dev: Key Considerations For Biopharma
Cytiva
Assure Scalability, Overcome Regulatory Hurdles, And Speed Time-To-Clinic
Ajinomoto Bio-Pharma Services
Risk vs. Resilience: Striking A Balance In The Biopharma Supply Chain
Sartorius
How Catalent Biologics Speeds Up Cell Line Development
Berkeley Lights
Early Development To Clinic: De-Risking A Bioconjugate’s Journey
Lonza
The GPEx Suite Of Technologies For Cell Line Development
Catalent
Meeting Oligo System Development Challenges Head-On
By Steve Foy
End-To-End Thinking During Drug Product Development
By Dr. Kashif Ghaffar
Developing A Disposable Grade-A Aseptic Fill/Finish Isolation System
By Martyn Ryder, SOLO Containment, an ILC Dover LP Company
Characterization Of Oligos, Related Impurities To Support Development
By Remco van Soest, Kerstin Pohl, Yunyun Zou, and Elliott Jones
Combination Device Regulatory Strategy: Success With The FDA
Premier Consulting
AAV Vector Manufacturing
Andelyn Biosciences
Prepare For Future Viral Vector Manufacturing
Cytiva
Analysis Of Clean-In-Place (CIP)
Seeq Corporation
Outsourcing Microbial Fermentation To A CMO: Key Considerations
Evonik Corporation
Development, Manufacture Of Biopharmaceuticals In Microbial Systems
Lonza
CQV Strategies To Optimize Cell Therapy Manufacturing
Project Farma
Scale-Up Of Antibody Production: From Bench To Pilot/Production
Eppendorf North America
Evaluation, Application Of Amsphere A3 In Purification Processes
JSR Life Sciences